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eratin 8 and 18 (K8/18) are the major components
of intermediate ﬁlament (IF) proteins of simple or
single-layered epithelia. Recent data show that normal
 
and malignant epithelial cells deﬁcient in K8/18 are nearly
100 times more sensitive to tumor necrosis factor (TNF)–
induced cell death. We have now identiﬁed human TNF
receptor type 1 (TNFR1)–associated death domain protein
(TRADD) to be the K18-interacting protein. Among IF
proteins tested in two-hybrid systems, TRADD speciﬁcally
bound K18 and K14, type I (acidic) keratins. The COOH-
terminal region of TRADD interacted with the coil Ia of the rod
domain of K18. Endogenous TRADD coimmunoprecipitated
K
 
with K18, and colocalized with K8/18 ﬁlaments in human
 
mammary epithelial cells. Overexpression of the NH
 
2
 
terminus (amino acids 1–270) of K18 containing the
TRADD-binding domain as well as overexpression of K8/
18 in SW13 cells, which are devoid of keratins, rendered
the cells more resistant to killing by TNF. We also showed
 
that overexpressed NH
 
2
 
 termini of K18 and K8/18 were
associated with endogenous TRADD in SW13 cells, resulting
in the inhibition of caspase-8 activation. These results indicate
that K18 may sequester TRADD to attenuate interactions
between TRADD and activated TNFR1 and moderate TNF-
induced apoptosis in simple epithelial cells.
 
Introduction
 
Intermediate filaments (IFs)* are major components of the
cytoskeleton and nuclear envelope in most types of eukaryotic
cells (Franke, 1987; Fuchs and Weber, 1994; Fuchs and
Cleveland, 1998). Although structural components of other
major cytoskeletal proteins, e.g., actin and tubulin, are highly
conserved in different cell types, constituent proteins of IFs
show intriguing molecular diversities and are expressed in
tissue-specific programs. The keratin subfamily, which is pref-
erentially expressed in epithelial cells, has over 20 members
(keratin 1–20) that form obligate noncovalent heteropolymers
of at least one type I (keratin 9–20) and one type II keratin
(keratin 1–8) (Moll et al., 1982). Keratin 8 and 18 (K8/18)
are the major components of the IFs of simple or single-
layered epithelia found in the gastrointestinal tract, liver,
exocrine pancreas, and mammary gland, from which many
carcinomas arise (Oshima et al., 1996). Gene targeting tech-
niques have been used to elucidate the function of K8/18. K8
knockout mice in one strain died around day 12 from unde-
termined tissue damage (Baribault et al., 1993), whereas in a
different strain, they survived to adulthood but colorectal hy-
perplasia and inflammation were present (Baribault et al.,
1994). K18 null mice were fertile, whereas old K18 null mice
developed a distinct liver pathology with abnormal hepato-
cytes containing K8-positive aggregates that resembled Mal-
lory bodies seen in human livers with alcoholic hepatitis (Ma-
gin et al., 1998). Together with a report describing a mutation
in the K18 gene in a patient with cryptogenic cirrhosis (Ku et
al., 1997), these findings suggest that K18 mutations may
possibly cause or result in a predisposition to liver disease
(Omary and Ku, 1997).
A recent report from Oshima’s group (Caulin et al., 2000)
addressed a new, fascinating function of K8/18, and ex-
plained the phenotypes of K8 or K18 knockout mice. They
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stated that normal and malignant epithelial cells deficient in
K8 and K18 are 
 
 
 
100 times more sensitive to tumor ne-
crosis factor (TNF)–induced cell death. K8 and K18 both
bind to the cytoplasmic domain of TNF receptor type 2
(TNFR2) and moderate the effects of TNF. This diminu-
tion may be a fundamental function of K8/18 seen in liver
regeneration, inflammatory bowel disease, hepatotoxin sen-
sitivity, and the persistent expression of these keratins in
many carcinomas (Caulin et al., 2000).
To further investigate the functions of K8/18, we screened a
yeast two-hybrid library, using K8 or K18 as a bait in order to
search for unidentified K8/18–associated proteins. Among the
positive clones, we found a clone encoding the COOH-termi-
nal portion of human TNFR1-associated death domain pro-
tein (TRADD), as a K18-interacting protein. We report here
evidence for the in vivo association of TRADD with K18, and
demonstrate that overexpression of the NH
 
2
 
 terminus (amino
acids [aa] 1–270) of K18 containing the TRADD binding do-
main as well as overexpression of K8/18 in SW13 cells, which
are devoid of keratins, rendered the cells more resistant to kill-
ing by TNF. We propose that sequestration of TRADD by
K18 may be one molecular mechanism by which epithelial cells
expressing keratins can be resistant to TNF-induced apoptosis.
 
Results
 
Identification of TRADD as a K18-interacting protein
 
To identify proteins interacting with K8/18, we screened a
human liver cDNA library, using the yeast two-hybrid pro-
cedure with full-length K8 or K18 as a bait. In the library
screening for K18, we earlier found that human Mrj, a DnaJ/
heat shock protein 40 (hsp40) family protein, directly inter-
acted with K18 as a cochaperone to regulate K8/18 filament
organization (Izawa et al., 2000). We have also identified a
clone that encodes the COOH-terminal region of TRADD
as a K18-interacting protein. TRADD is a 34-kD protein
that interacts specifically with TNFR1 (Hsu et al., 1995). In
the initial step of TNFR1 signaling, TNF binds to the extra-
cellular domain of TNFR1 and induces receptor trimeriza-
tion (Banner et al., 1993). Next, the death domain of
TNFR1 recruits the adaptor protein TRADD (Hsu et al.,
1995). TRADD, in turn, binds Fas-associated death domain
(FADD), TNFR-associated factor 2, and RIP, and activates
the downstream signaling pathway leading to apoptosis (Hsu
et al., 1996; Yeh et al., 1997), JNK/SAPK activation (Hsu et
al., 1996; Liu et al., 1996; Yeh et al., 1997), and nuclear fac-
tor-
 
 
 
B (NF-
 
 
 
B) activation (Hsu et al., 1996; Kelliher et al.,
1998). To determine the role of K8/18 in TNF signaling, we
further analyzed the TRADD–K18 interaction. The human
TRADD cDNA encodes a 312-aa protein, and the clone de-
rived from the liver library contained residues 245 to 312 of
TRADD, hereafter termed TRADD-C (Fig. 1 A). The
TRADD-C fragment is the COOH-terminal part of the
death domain of TRADD mediating the interaction between
TRADD and the death domain of TNFR1, FADD, and
RIP. To confirm that full-length TRADD (TRADD-F) in-
teracts with K18 and to determine if TRADD can bind to
other IF proteins, we examined the interaction of TRADD-F
and TRADD-C with K5, K8, K14, K18, and type III IF
proteins in the two-hybrid system (Fig. 1 B). TRADD-C
strongly interacted with K14 and K18, type I (acidic) ker-
atins, but did not interact with K5, K8, vimentin, glial fibril-
lary acidic protein (GFAP), or desmin. In the same fashion,
TRADD-F specifically interacted with K14 and K18. We
next analyzed the region of K18 that contained the TRADD
interaction site. For this, the binding between a series of
truncations of K18 and TRADD-F or TRADD-C was deter-
mined using the two-hybrid system (Fig. 1 C). The coil Ia re-
gion of the rod domain of K18 specifically interacted with
both TRADD-F and TRADD-C.
 
Direct association of TRADD with K8/18 in vitro
 
Next we analyzed the in vitro direct association of TRADD, us-
ing a cosedimentation assay (Fig. 2). As the separation of K8, vi-
Figure 1. Identification of TRADD as a K18-interacting protein. 
(A) Domain organization of human TRADD protein. Death domain 
(DD) is indicated. Position of the original clone encoding the 
COOH-terminal region of TRADD (TRADD-C) is also indicated. 
Numbers refer to amino acid position. (B) Interactions of TRADD-C 
or full-length TRADD (TRADD-F) with K18 or other IFs in two-
hybrid system. Y190 cells cotransformed with various pGBD-C1-IFs 
and pGAD-C1-TRADD-F or pGAD-C1-TRADD-C were selected in 
minus tryptophan (Trp)-leucine (Leu) media and subjected to 
 -galactosidase filter assay. The numbers of plus signs represent the 
relative rates at which the transformed yeast colonies turned blue 
after incubation at 30 C on filters,    ,  3 h;   , 3–8 h;  ,  8 h. 
Minus sign represents colonies remaining white at 24 h. (C) Iden-
tification of the coil Ia region of K18 that is sufficient for binding to 
TRADD. Y190 cells cotransformed with various pGBD-C1-K18 dele-
tion mutants and pGAD-C1-TRADD-F or pGAD-C1-TRADD-C were 
selected in minus Trp-Leu media and subjected to  -galactosidase 
filter assay. Plus and minus signs are the same as in B. Numbers 
refer to amino acid position. 
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mentin or desmin, and recombinant TRADD protein (pro-
duced as a glutathione 
 
S
 
-transferase [GST] fusion; GST–
TRADD) in the Coomassie brilliant blue–stained gel after
SDS-PAGE was not clear (Fig. 2 A), the samples were also de-
tected with an anti-GST antibody. After immunoblotting, the
proportions of supernatant and precipitated GST–TRADD
were revealed (Fig. 2 B). Incubation in filament assembly buffer
induced a rapid polymerization of K8 and K18 (Fig. 2 A, lane
1). As a control, recombinant GST was not sedimented in the
presence of K8/18 (Fig. 2 A and B, lane 3). In the absence of
K8/18, GST–TRADD was not sedimented (Fig. 2 A and B,
lane 4), but in the presence of K8/18, a substantial portion of
GST–TRADD was precipitated (Fig. 2 A and B, lane 5). Be-
cause TRADD interacted with K18, but not with K8 in the
two-hybrid analysis, the TRADD sedimenting with K8/18 was
thought to be associated with the K8/18 polymer via direct
binding to K18. In addition, TRADD did not sediment with
vimentin (Fig. 2 A and B, lane 6) or desmin (Fig. 2 A and B,
lane 7), findings consistent with results obtained using the two-
hybrid method.
 
Overexpressed myc-tagged TRADD colocalizes with 
K8/18 filaments
 
In attempts to characterize the K18–TRADD association in
vivo, we first determined the subcellular localization of over-
expressed myc-tagged TRADD in various epithelial cells. We
transfected HeLa cells, T24 cells, MDCK cells, and immortal-
ized human mammary epithelial cells (HMEC) with a myc-
tagged vector encoding the full-length TRADD. 16 h later,
the cells were fixed and doubly stained with anti-myc poly-
clonal antibody and anti-K18 monoclonal antibody (Fig. 3
A). In various cells, overexpressed myc–TRADD exhibited a
filamentous pattern, and these myc–TRADD filaments mark-
edly colocalized with K8/18 filaments (Fig. 3 A). Overex-
pressed myc–TRADD did not colocalize with either actin
filaments or microtubules (unpublished data). The overex-
Figure 2. Cosedimentation of TRADD with K8/18. K8/18 
filaments were assembled in the absence (lane 1) or presence of 
GST (lane 3), or GST–TRADD (lane 5). As a control, only GST (lane 
2) or GST–TRADD protein (lane 4) was incubated in the assembly 
buffer. Vimentin (lane 6) or desmin filaments (lane 7) were assem-
bled in the presence of GST–TRADD. The supernatant (S) and pellet 
(P) fractions were analyzed by SDS-PAGE, and stained with 
Coomassie brilliant blue (A), or detected with anti-GST antibody by 
immunoblotting (B). Substantial portions of GST–TRADD were sedi-
mented with K8/18. GST–TRADD was not sedimented with either 
vimentin or desmin under these conditions. The arrowhead and 
arrow indicate positions of GST and GST–TRADD, respectively. 
Molecular size markers are shown on the left.
Figure 3. Overexpressed, myc-tagged TRADD colocalizes with 
K8/18 filaments. (A) Subcellular distribution of overexpressed myc-
tagged TRADD in various epithelial cells. pRK5–myc-TRADD vectors 
were transfected into HeLa cells, T24 cells, MDCK cells, and immor-
talized HMEC. The transfected cells were fixed 16 h later and doubly 
stained with anti-myc antibody and anti-K18 antibody. The merged 
images are also shown. (B) Subcellular distribution of overexpressed 
myc-tagged TRADD, FADD, caspase-2, and caspase-8 in HeLa cells. 
These myc-tagged proteins were overexpressed in HeLa cells in the 
presence of 20  M zVAD-fmk. The transfected cells were doubly 
stained with anti-myc antibody and anti-K18 antibody. The merged 
images are also shown. Bars, 10  m. 
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pression of the death domain of TRADD also resulted in a cy-
tosolic filamentous distribution (unpublished data). Because it
is reported that FADD and caspase-8/FLICE (Perez and
White, 1998; Siegel et al., 1998), containing death effector
domains, and caspase-2 (Colussi et al., 1998) and Bcl10
(Guiet and Vito, 2000), containing a caspase recruitment do-
main, form cytoplasmic filamentous structures when overex-
pressed, we examined whether overexpressed FADD, cas-
pase-8, or caspase-2 colocalized with K8/18. To do this, we
overexpressed myc-tagged, full-length TRADD, FADD, cas-
pase-8, or caspase-2 in HeLa cells in the presence of 20 
 
 
 
M
zVAD-fmk, a caspase inhibitor that inhibits apoptosis, and
the cells were doubly stained for myc and K18 (Fig. 3 B). In
the presence of zVAD-fmk, overexpressed myc–TRADD
colocalized with K8/18 filaments, as described above. Overex-
pressed myc–FADD formed filamentous structures, but these
filaments did not colocalize with K8/18 filaments; a result
consistent with a report that the filamentous structures formed
by FADD and caspase-8 did not colocalize with known cyto-
skeletal elements including IFs (Siegel et al., 1998). As it was
reported that death effector domain mutants of caspase-8
could form filamentous structures but full-length caspase-8
showed a diffuse distribution (Perez and White, 1998; Siegel
et al., 1998), overexpressed myc–full-length caspase-8 showed
a diffuse distribution, and did not show colocalization with
K8/18 filaments. Overexpressed myc–caspase-2 showed both
cytoplasmic and nuclear localization as previously reported
(Colussi et al., 1998), and did not colocalize with K8/18 fila-
ments. These results suggest that among the apoptosis-related
proteins overexpressed in this study, TRADD is specifically
associated with K8/18 filaments.
 
Endogenous TRADD is associated with K18 in vivo
 
To explore the interaction between native TRADD and K18,
polyclonal antibodies were raised against TRADD, using
the purified histidine (His)
 
6
 
-tagged NH
 
2
 
-terminal region of
TRADD (TRADD-N) as the immunogen. Affinity-puri-
fied  rabbit anti-TRADD antibody specifically recognized a
polypeptide with a relative molecular mass of 34 kD in lysates
obtained from immortalized HMEC (Fig. 4 A), as well as in
those from HeLa, T24, and MDCK cells (unpublished data).
Preincubation of the antibody with the immunogen selectively
inhibited the immunoreactivity (Fig. 4 A). Since HMEC,
which are immortalized by retroviral expression of the catalytic
component of human telomerase, maintain normal natures of
HMEC (Kiyono et al., 1998) and express the highest level of
TRADD among the cells we tested, we mainly used HMEC in
the following experiments. Using the rabbit anti-TRADD an-
tibody, we precipitated complexes containing TRADD pro-
teins from 1% NP-40 soluble fraction of HMEC lysates (Fig. 4
B). TRADD was immunoprecipitated with anti-TRADD an-
tibody, but not with control rabbit IgG. K18 was coimmuno-
precipitated with TRADD, using the anti-TRADD antibody.
These results indicate that TRADD is associated with K18, in
vivo. To determine the intracellular distribution of TRADD
and to check if TRADD colocalizes with K8/18 filament net-
works, HMEC were fixed with 50% methanol/50% acetone
and double stained with anti-TRADD polyclonal antibody
and anti-K18 monoclonal antibody. TRADD was present in
the cytoplasm and showed some filamentous patterns, and
there was a significant overlap between filamentous TRADD
and K18 (Fig. 4 C, a–c). When we determined if TRADD
colocalized with other major cytoskeletal components, e.g., ac-
tin filaments and microtubules, double staining showed no ap-
parent codistribution of TRADD with actin filaments or with
microtubules (unpublished data). To further confirm the colo-
calization of TRADD with K18, we transfected HMEC with a
K8 deletion mutant to disrupt K8/18 filaments, and then ob-
served the distribution of TRADD (Fig. 4 C, d–f). Cells ex-
pressing the myc-tagged K8 deletion mutant (aa 1–239 of K8)
showed disorganization of K8/18 filaments (unpublished data)
and the disappearance of the filamentous distribution of
TRADD. These results confirm the colocalization of TRADD
with K8/18 filaments, and suggest that K8/18 filament organi-
zation affects the subcellular distribution of TRADD.
Figure 4. In vivo association of K18 with TRADD. (A) Detection of 
TRADD in HMEC. Lysates from HMEC were stained with Coomassie 
brilliant blue (CBB), detected with anti-TRADD antibody by immuno-
blotting ( -TRADD), or immunostained with anti-TRADD antibody 
preabsorbed by an immunogen (Absorbed). Anti-TRADD antibody 
specifically recognized bands of  34 kD. Molecular size markers are 
shown on the left. (B) Interactions of TRADD with K18 in vivo. 
Immunoprecipitates were prepared from lysates of HMEC, using 
control rabbit IgG and anti-TRADD polyclonal antibody. Each 
precipitate, separated into two parts, was subjected to Western 
blotting with anti-TRADD monoclonal or anti-K18 monoclonal 
antibody. (C) (a–c) Colocalization of TRADD and K8/18 filaments in 
HMEC. HMEC were double stained with anti-TRADD antibody (a) 
and anti-K18 antibody (b). The merged image of a and b is shown (c). 
(d–f) Effects of the expression of the myc-K8 deletion mutant on the 
subcellular distribution of TRADD in HMEC. pRK5–myc-K8 deletion 
mutant vectors were transfected into HMEC. The cells were fixed
16 h later and doubly stained with anti-TRADD antibody (d) and 
anti-myc antibody (e). The merged image of d and e is shown (f). 
A transfected cell (arrow) and an untransfected cell (arrowhead) are 
shown. Bar, 20  m. 
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A high dose of TNF treatment leads to release of 
TRADD from K18
 
Since TRADD is a TNFR1 adaptor protein recruited to
the TNFR1 in a TNF-dependent manner, we next deter-
mined if TNF stimulation would affect K18–TRADD as-
sociation. To observe effects of TNF treatment on the
subcellular distribution of TRADD, HMEC were un-
treated or incubated for 20 min with increasing concentra-
tions of TNF, and then doubly stained for TRADD and
K18 (Fig. 5 A). At the physiological concentration of TNF
(3 ng/ml), there were no apparent changes in the colocal-
ization of TRADD and K18. At 30 ng/ml of TNF, the fil-
amentous pattern of TRADD distribution began to di-
minish (unpublished data). At the high dose of TNF (100
ng/ml), TRADD dissociated from K8/18 filaments, and
dispersed diffusely (Fig. 5 A). We next checked the bind-
ing of TRADD with K18 after TNF treatment by immu-
noprecipitation (Fig. 5 B). Lysates prepared from HMEC
treated for 20 min with various doses of TNF, or left un-
treated, were immunoprecipitated with anti-TRADD an-
tibody, and the presence of K18 or TNFR1 in the
TRADD immune complex was examined. Coprecipitating
K18 was readily detected in lysates from untreated (con-
trol) cells and physiological dose TNF (3 ng/ml)–treated
cells but was barely visible in the 100 ng/ml TNF-treated
samples. Immunoprecipitates formed with control rabbit
IgG contained a much smaller amount of K18 than those
immunoprecipitated with anti-TRADD antibody (Fig. 4
B). The negligible amount of K18 immunoprecipitated by
control rabbit IgG did not change with various doses of
TNF treatment (unpublished data). In contrast, coprecip-
itating TNFR1 was barely visible in the case of 3 ng/ml of
TNF but was readily visible at 100 ng/ml of TNF. Thus,
K18 and TRADD are preassociated in unstimulated con-
ditions. Furthermore, the dissociation of TRADD from
K18 and the recruitment of TRADD to activated TNFR1
became obvious in the presence of high concentrations of
TNF in HMEC. We then examined the induction of
apoptosis after treatment of TNF in HMEC. HMEC were
 
Figure 5.
 
Dissociation of TRADD from K18 after TNF treatment.
 
 
(A) Subcellular distribution of TRADD after TNF treatment. HMEC 
were untreated or incubated for 20 min with increasing concentra-
tions of TNF, and then costained for TRADD and K18. (B) TRADD is 
released from K18 and recruited to TNFR1 after TNF stimulation. 
Lysates prepared from HME cells treated for 20 min with the 
indicated doses of TNF were immunoprecipitated with anti-TRADD 
antibody. Coprecipitating K18 or TNFR1 were detected with 
anti-K18, or anti-TNFR1 antibody, respectively. (C) Effects of TNF 
treatment on cell viability. HMEC were treated with various doses of 
TNF for 12 h in the presence of 1 
 
 
 
g/ml of CHX. After the treatment, 
cell viability was determined by Trypan blue staining. Experiments 
were repeated at least three times per condition. Standard error is 
represented by bars. (D) Time course of the subcellular distribution of 
TRADD and the appearance of the active form of caspase-8 after 
TNF treatment in HMEC. HMEC were treated with 100 ng/ml TNF in 
the presence of 1 
 
 
 
g/ml CHX for 0, 0.5, 1, 3, and 6 h, and stained 
with anti-TRADD antibody (a) or doubly stained with anti-h8D401 
antibody, which recognizes the active form of caspase-8 and propid-
ium iodide (PI) (b). The active form of caspase-8 began to be detected 3 h 
after the treatment (arrow). Some of activated caspase-8–positive cells 
showed the abnormal appearance of nuclei (arrowhead). Bars, 10 
 
 
 
m. 
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treated for 24 h with increasing concentrations of TNF in
the presence of 1 
 
 
 
g/ml cycloheximide (CHX), to inhibit
the production of protective proteins, and cell viability
was evaluated by Trypan blue staining. Most HMEC were
viable after incubation with physiological concentrations
(1–3 ng/ml) of TNF, but viable cells markedly decreased
in cases of high concentrations (100–300 ng/ml) of TNF
(Fig. 5 C). Thus, high concentrations of TNF are neces-
sary for the full induction of apoptosis in HMEC, a no-
tion consistent with the observation that normal and
malignant epithelial cells containing K8 and K18 are
 
 
 
100 times more insensitive to TNF-induced death com-
pared with the cells deficient in K8 and K18 (Caulin
et al., 2000). Taken together, these data show that high
concentrations of TNF are necessary for the release of
TRADD from K18, the binding of TRADD with acti-
vated TNFR1, and full induction of apoptosis. Because
TRADD is an indispensable adaptor molecule for TNFR1
signal transmission to downstream cascades, K18 may
have an inhibitory effect on TNF-induced apoptosis
by competing with activated TNFR1 for binding to
TRADD. In TNFR1-induced cell death signaling, FADD
couples the TNFR1–TRADD complexes to activation of
caspase-8 by recruiting procaspase-8 (also called a FLICE
or MACH) to the receptor complex (Boldin et al., 1996;
Muzio et al., 1996). The recruitment of procaspase-8 ap-
pears to result in its oligomerization, activation of its auto-
proteolytic activity, and ultimately the generation of enzy-
matically active caspase-8 (Yeh et al., 1998; Zhang et al.,
1998), which in turn cleaves other caspases, thereby initi-
ating apoptosis. Since TNFR1 did not induce apoptosis in
FADD-deficient embryonic fibroblasts (Yeh et al., 1998),
the TRADD–FADD–caspase-8 complex formation and
the activation of caspase-8 are thought to be early and cen-
tral events in TNFR1-induced apoptosis. The complex
formation was first described as the death-inducing signal-
ing complex (DISC) formation in CD95/APO-1/Fas-
induced apoptosis (Kischkel et al., 1995; Medema et al.,
1997). To further characterize the time course of the
TNFR1-induced apoptosis in HMEC, we prepared an af-
finity-purified rabbit antibody (anti-h8D401 antibody)
that recognizes the active form but not the proform of hu-
man caspase-8. The anti-h8D401 antibody showed the
same specificity as the anti-m8D387 antibody that was
raised against a cleavage site of mouse caspase-8 (Kouroku
et al., 2000a,b), and did not react with the active form of
other caspases (unpublished data). Using the anti-h8D401
antibody, we compared the time courses of the subcellular
distribution of TRADD and the appearance of the active
form of caspase-8 (Fig. 5 D). 30 min after the treatment
of HMEC with 100 ng/ml TNF and 1 
 
 
 
g/ml CHX,
TRADD dispersed diffusely as described above, and this
diffuse distribution did not change during the observed
period (Fig. 5 D, a). The active form of caspase-8 began to
be detected in 
 
 
 
5% of the cells 3 h after treatment (Fig. 5
D, b). Some of the activated caspase-8–positive cells
showed the abnormal appearance of a nucleus. These re-
sults demonstrated that the activation of caspase-8 oc-
curred after the dissociation of TRADD from K18 in
HMEC, which is consistent with our model that K18
Figure 6. Other apoptotic stimuli do not affect TRADD–K18 
interaction. (A) Effects of various apoptotic stimuli on the subcellular 
distribution of TRADD. HMEC were incubated for 20 min with 1 
 M of ACR, 10  g/ml of NCS, or 1  M of taxol, and then costained 
for TRADD and K18. HMEC were also subjected to immunostaining 
20 min after exposure to 100 J/m
2 UVC. (B) Various apoptotic 
stimuli, except TNF, did not alter association of TRADD with K18. 
Lysates prepared from HMEC treated with various stimuli, as 
described in A, were immunoprecipitated with anti-TRADD anti-
body. Coprecipitating K18 or TNFR1 were detected with ant-K18 or 
anti-TNFR1 antibody, respectively. (C) Induction of apoptosis after 
the treatment with various apoptotic stimuli. To check for the 
induction of apoptosis, HMEC were fixed 24 h after treatment, and 
counted for the presence of condensed chromatin and fragmented 
nuclei (DAPI stain). Bar, 10  m.  
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may have an inhibitory effect on TNF-induced apoptosis
by competing with activated TNFR1 for binding to
TRADD.
 
Effects of various apoptotic stimuli on the intracellular 
distribution of TRADD
 
To search for the role of K18–TRADD interaction in cellu-
lar responses to various apoptotic stimuli, we treated HMEC
with 1 
 
 
 
M aclarubicin (ACR), a topoisomerase inhibitor,
10 
 
 
 
g/ml neocarzinostatin (NCS), a chemical that directly
causes DNA breaks, 1 
 
 
 
M taxol, a microtubule stabilizer,
and UV irradiation (100 J/m
 
2
 
). 20 min after treatment with
these stimuli, we examined the distribution of TRADD us-
ing immunostaining techniques (Fig. 6 A). In contrast to
TNF treatment (Fig. 5 A), these stimuli did not alter subcel-
lular distribution of TRADD. We also checked TRADD–
K18 binding after these treatments using immunoprecipita-
tion methods (Fig. 6 B). TRADD remained associated with
K18 and was not recruited to TNFR1. Immunoprecipitates
formed with control rabbit IgG contained a much smaller
amount of K18 than those formed with anti-TRADD anti-
body (Fig. 4 B). The negligible amount of K18 immunopre-
cipitated by control rabbit IgG did not change after these
treatments (unpublished data). 24 h after treatment, we ex-
amined the induction of apoptosis in HMEC by counting
the number of cells showing apoptotic, condensed nuclei.
We found that all these treatments induced marked apopto-
sis as shown in Fig. 6 C. These results indicate that among
various apoptotic stimuli, the release of TRADD from K18
occurs specifically after TNF treatment.
 
Overexpressing the NH
 
2
 
 terminus (aa 1–270) of K18 
inhibits TNF-induced apoptosis
 
To further show the involvement of K18 in TNF-induced
cell death in HMEC, we examined the effects of overex-
pressing either K8/18 or the NH
 
2
 
 terminus of K18 (aa
1–270), which contains the TRADD binding site, on TNF-
induced apoptosis. We transiently transfected Epstein-Barr
virus–based vectors into cells expressing the trans-acting Ep-
stein-Barr virus–associated nuclear antigen (EBNA)-1 gene
to obtain extremely high transformation efficiency as well as
high expression level of transferred genes (Yasui et al., 1998).
We first obtained EBNA-expressing SW13 cells, which lack
endogenous keratin and vimentin. These EBNA-expressing
SW13 cells were then transiently transfected with pDR2
vectors expressing myc-tagged K8 and K18, myc-tagged
NH
 
2
 
 terminus of K18 (aa 1–270), or vimentin, using lipo-
fection. 24 h after the transfection, the cells were treated
with 1 ng/ml TNF in the presence of 1 
 
 
 
g/ml CHX or incu-
bated only with 1 
 
 
 
g/ml CHX. After another 24 h, the cells
were stained with anti-myc antibody or antivimentin anti-
body to detect the transfected cells, and with DAPI to ob-
serve nuclei. To determine the percentage of viable cells, the
number of transfected cells showing no apoptotic nuclei
(condensed chromatin and fragmented nuclei) was deter-
mined, and cell viability was expressed as a ratio of the per-
centage of viable cells in the presence of TNF to those in the
absence of TNF. As shown in Fig. 7 A, cells expressing the
NH
 
2
 
 terminus of K18 as well as those expressing K8/18
were more resistant to TNF-induced cytotoxicity than the
cells transfected with control vectors or vimentin expression
vectors. We also checked the expression of TNFR1 and
TRADD in EBNA-expressing SW13 cells by immunoblot-
ting. The expression of endogenous TNFR1 and TRADD
was detected in EBNA-expressing SW13 cells (Fig. 7 B) at a
level almost comparable to that found in parent SW13 cells
and HMEC (unpublished data). To confirm that the resis-
tance to TNF-induced apoptosis was caused by the associa-
tion of TRADD with overexpressed K8/18 or the NH
 
2
 
 ter-
minus of K18, we observed the subcellular localization of
endogenous TRADD and overexpressed K8/18 or NH
 
2
 
 ter-
minus of K18 in the SW13 cells. In untransfected SW13
cells, which are devoid of keratins, native TRADD was dif-
fusely present in the cytoplasm (Fig. 7 C, a). In K8/
18–transfected SW13 cells, TRADD was recruited to over-
expressed K8/18 filaments (Fig. 7 C, d–f). In cells overex-
pressing the NH
 
2
 
 terminus of K18, TRADD markedly colo-
calized with the overexpressed NH
 
2
 
 terminus (Fig. 7 C, g–i).
These results indicate that overexpressed K8/18 or K18
NH
 
2
 
 terminus could sequester endogenous TRADD, lead-
ing to the inhibition of TNF-induced apoptosis in SW13
cells. We then determined if overexpressing K8/18 or the
NH
 
2
 
 terminus of K18 could affect the activation of caspase-8,
an early and central event of TNFR1-induced cell death
signaling as described earlier (Fig. 7 D). Using anti-h8D401
antibody, which recognizes the active form but not the pro-
form of human caspase-8, the activation of caspase-8 began
to be detected in 
 
 
 
6% of SW13 cells 4 h after the treatment
with 1 ng/ml TNF in the presence of 1 
 
 
 
g/ml CHX. 24 h
after the transfection, the cells were treated with 1 ng/ml
TNF in the presence of 1 
 
 
 
g/ml CHX for 4 h, and then
fixed and doubly stained with anti-myc antibody or antivi-
mentin antibody, to detect the transfected cells, and with
anti-h8D401 antibody, to detect the activation of caspase-8.
As shown in Fig. 7 D, cells overexpressing the NH
 
2
 
 terminus
of K18 as well as those overexpressing K8/18 showed less
positive staining for the active form of caspase-8 than the
cells transfected with control vectors or vimentin expression
vectors. After the treatment with 1 
 
 
 
g/ml CHX only,
 
 
 
0.5% of both SW13 cells and cells transfected with these
vectors showed positive staining for activated caspase-8 (un-
published data). These results indicate that K18 could affect
TNF-induced death signaling in a step upstream of cas-
pase-8 activation, which strongly supports our model that
K18 sequesters TRADD and inhibits the recruitment of
TRADD to activated TNFR1, leading to the inhibition of
DISC formation (TRADD–FADD–caspase-8) and cas-
pase-8 activation. Next, we asked if the overexpression of the
NH
 
2 
 
terminus of K18 or K8/18 only protect cells from
TNF-induced apoptosis. To this end, 24 h after the transfec-
tion, in the same fashion as described above, the cells were
left untreated or were treated with 0.3 
 
 
 
M ACR, 1 
 
 
 
g/ml
NCS, 1 
 
 
 
M taxol, or UV irradiation (30 J/m
 
2
 
). After an-
other 24 h, the cells were fixed and the percentages of viable
cells were recorded (Fig. 7 E). We observed no effects from
the overexpression of K8/18, the NH
 
2
 
 terminus of K18, or
vimentin on the survival rates of cells after treatment with
these various apoptotic stimuli. These results demonstrate
that K8/18 protects the cell specifically from TNF cytotoxic-
ity, as reported by Oshima’s group (Caulin et al., 2000). 
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Figure 7.
 
Overexpression of the NH
 
2
 
 terminus of K18 inhibits TNF-induced apoptosis. 
 
(A) SW13 cells expressing K8/18 and the NH
 
2
 
 
terminus (aa 1–270) of K18 exhibit decreased sensitivity to TNF-induced apoptosis compared with cells transfected with control vectors or 
vimentin expression vectors. The EBNA-expressing SW13 cells were transiently transfected with pDR2 vectors expressing myc-tagged K8 and 
K18 (K8/18), myc-tagged NH
 
2
 
 terminus (residues 1–270) of K18 (K18 N), or vimentin, using lipofectamine. 24 h after the transfection, the 
cells were treated with 1 ng/ml TNF in the presence of 1 
 
 
 
g/ml of CHX or only incubated with 1 
 
 
 
g/ml of CHX. After another 24 h, the cells 
were stained with anti-myc antibody or antivimentin antibody, to detect the transfected cells, and with DAPI, to see nuclei. To obtain the 
percentage of living cells, the number of transfected cells showing no apoptotic nuclei (condensed chromatin and fragmented nuclei) was 
determined, and cell viability was expressed as a ratio of percentage of viable cells in the presence of TNF to those in the absence of TNF. 
Experiments were repeated at least three times per condition. Standard error is represented by bars. (B) Expression of TNFR1 and TRADD in 
EBNA-expressing SW13 cells. Lysates prepared from EBNA-expressing SW13 cells were subjected to immunoblotting with anti-TNFR1 
antibody (lane 1) or anti-TRADD antibody (lane 2). The arrowhead and arrow indicate positions of TNFR1 and TRADD, respectively. Molec-
ular size markers are shown on the left. (C) Subcellular distribution of endogenous TRADD and overexpressed myc-tagged K8/18 or NH
 
2
 
 
terminus of K18 (K18 N) in SW13 cells. The untransfected, EBNA-expressing SW13 cells were doubly stained with anti-TRADD antibody (a) 
and anti-myc antibody (b). The myc-tagged K8/18–transfected cells were doubly stained with anti-TRADD antibody (d) and anti-myc 
antibody (e). The cells expressing myc-tagged K18 N were doubly stained with anti-TRADD antibody (g) and anti-myc antibody (h). The 
merged images of a and b (c), d and e (f), and g and h (i) are shown. (D) Overexpression of K8/18 or the NH
 
2
 
 terminus of K18 (K18 N) inhibits  
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Furthermore, these results support our model that K18 may
exert antiapoptotic functions via association with TRADD.
 
Discussion
 
The recent study by Oshima’s group (Caulin et al., 2000)
provided evidence for K8/18’s key role in moderating the
signaling of TNF. They found that decreasing levels of K8
and K18 in cultured epithelial cells increases cellular sensi-
tivity to killing by TNF due to binding of both K8 and K18
with the cytoplasmic domain of TNFR2. They also demon-
strated that K8 and K18 diminish the TNF-dependent acti-
vation of Jun NH
 
2
 
-terminal kinase (JNK) and the NF-
 
 
 
B
transcriptional factor. Using an in vivo model, these same
authors found that mice without K8 or K18 are more sensi-
tive to TNF-mediated apoptotic liver damage (Caulin et al.,
2000). Here we uncovered an alternative molecular mecha-
nism by which epithelial cells can be resistant to TNF-
induced cytotoxicity. Our data obtained in vitro and in vivo
provide support for the notion of a direct association of K18
with TRADD, an indispensable adaptor molecule for
TNFR1 signaling. Thus, K18 may sequester TRADD to at-
tenuate the interaction of TRADD with activated TNFR1,
leading to diminution of TNF-induced apoptosis.
In HMEC, in unstimulated conditions, TRADD is asso-
ciated with K18, but not with TNFR1 (Fig. 5 and Fig. 7 F,
a). Treatment with high concentrations of TNF stimuli re-
sulted in dissociation of TRADD from K18, the recruitment
of TRADD to TNFR1, and the full induction of apoptosis,
whereas treatment with the physiological concentration of
TNF did not lead to a release of TRADD from K18 or
marked induction of apoptosis (Fig. 5). These observations
suggest that upon TNF ligation, the binding of TRADD to
K18 may serve as a negative regulatory mechanism, govern-
ing the rate of TRADD association with activated TNFR1
(Fig. 7 F, b). Lack or dysfunction of K18 may free TRADD
to facilitate the association of TRADD with activated
TNFR1 (Fig. 7 F, c). As shown in Fig. 7 A, B, and E, we
also found that overexpression of K8/18 and the NH
 
2
 
-ter-
minus (aa 1–270) of K18, which contains the TRADD
binding domain, could specifically inhibit TNF-induced
apoptosis. We further showed that overexpressed K8/18 or
NH
 
2
 
-terminal fragment of K18 could sequester endogenous
TRADD in SW13 cells (Fig. 7 C), and that K18 could affect
TNF-induced cell death signaling in a step upstream of cas-
pase-8 activation (Fig. 7 D). These results suggest a molecu-
lar mechanism where K18 sequesters TRADD and affects
the recruitment of TRADD to activated TNFR1, leading to
the inhibition of the formation of DISC (TRADD–FADD–
caspase-8) and the activation of caspase-8. Our data, de-
scribed above, clearly show that K18 could attenuate TNF-
induced cell death through association with TRADD in at
least some kinds of simple epithelial cells. Since effects of
TNF are complex and vary in cells of different lineage and
differentiation stage, it is necessary to investigate roles of
K18–TRADD interactions in simple epithelial cells of vari-
ous lineage and differentiation stages in future research.
The sequestering of TRADD by K18 seems reminiscent
of the sequestering of Smads by microtubules (Dong et al.,
2000). In the TGF
 
 
 
 pathway, microtubules serve as a cyto-
plasmic sequestering network for Smads in unstimulated
cells. TGF  triggers dissociation of Smads from microtu-
bules, and phosphorylation and nuclear localization of
Smad2 and 3 with consequent activation of transcription in-
side the nucleus (Dong et al., 2000). In addition, it was re-
ported that MIP-T3 sequesters TNFR-associated factor 3 to
microtubules (Ling and Goeddel, 2000). In this context, it
was discovered that depolymerization of microtubules acti-
vates NF- B, findings that suggest a role for NF- B in sens-
ing changes in the state of the cytoskeleton and converting
them to changes in gene activity (Rosette and Karin, 1995).
Taken together, these observations suggest that the seques-
tering of adaptor molecules for receptors by cytoskeletal pro-
teins may represent a general mechanism by which cytoskel-
etal proteins affect cellular signaling and thereby transmit
morphology-related information.
In a two-hybrid system, TRADD specifically bound K18
and K14, type I (acidic) keratins, but did not bind type II
keratins, including K5 and K8, or type III IFs, including
vimentin, GFAP, and desmin (Fig. 1 B). K14 is preferen-
tially expressed in the basal layer of epidermis, and in the
same fashion as K18, it is possible that epidermal K14
may function as an inhibitor of TNF–TNFR1 signaling
through an association with TRADD. Accumulating evi-
dence, including data on mice that are null for the mole-
cules involved in NF- B signaling, suggests that NF- B
plays a particularly central role in epidermal biology (Kauf-
man and Fuchs, 2000). By linking cell cycle withdrawal
and protection from apoptosis, NF- B can coordinate and
monitor both homeostasis within the epidermis as well as
transition of the epidermal cell from basal to suprabasal
layers (Kaufman and Fuchs, 2000). Our present data shed
new light on a role of keratins in the regulation of NF- B
signaling in the skin.
By way of summary, we found that K18 directly interacts
with TRADD, and we postulate that K18 may suppress TNF–
TNFR1-induced apoptosis by associating with TRADD.
These observations pave the way for ongoing research on the
the activation of caspase-8 in SW13 cells. The EBNA-expressing SW13 cells were transiently transfected as in A. 24 h after the transfection, 
the cells were treated with 1 ng/ml TNF in the presence of 1  g/ml CHX for 4 h, and then doubly stained with anti-myc antibody or a
ntivimentin antibody, to detect the transfected cells, and with anti-h8D401 antibody, which recognizes the active form of caspase-8. The 
percentages of transfected cells showing positive staining for the active form of caspase-8 were determined. Experiments were repeated at 
least three times per condition. Standard error is represented by bars. (E) K18 has cell-protective effects specifically on TNF cytotoxicity. 24 h 
after the transfection, in the same fashion as described in A, the cells were left untreated or treated with 0.3  M of ACR, 1  g/ml of NCS, 1 
 M of taxol, or 30 J/m2 of UVC irradiation. After another 24 h, the cells were fixed and the percentages of living cells were determined as in 
A. (F) Models for K18-dependent moderation of TNF–TNFR1 signaling in epithelial cells. TRADD is associated with K18, but not with TNFR1 
in unstimulated conditions (a). Upon TNF ligation, the binding of TRADD to K18 may serve as a negative regulatory mechanism, governing 
the rate of TRADD association with activated TNFR1 (b). Lack or dysfunction of K18 may free TRADD to facilitate the association of TRADD 
with activated TNFR1 (c). Bar, 10  m.424 The Journal of Cell Biology | Volume 155, Number 3, 2001
dissection of cross talk between keratin IF and intracellular sig-
naling as well as for a better understanding of the biology of
cancer cells transformed from simple epithelial cells.
Materials and methods
Cell culture and reagents
HeLa cells, human bladder cell carcinoma T24 cells, and MDCK cells were
grown in Dulbecco’s modified Eagle’s medium supplemented with 10% fe-
tal bovine serum and penicillin in an air-5% CO2 atmosphere with constant
humidity. HMEC were immortalized by retroviral gene transfer of a cDNA
encoding the catalytic component of human telomerase (pLXSN-fhTERT),
which was provided by Dr. D.A. Galloway (Fred Hutchinson Cancer Re-
search Center, Seattle, WA), and grown as described (Kiyono et al., 1998).
The human adenocarcinoma cell line SW13, which is devoid of both ker-
atins and vimentin, was grown as described (Sarria et al., 1990). TNF ,
CHX, and taxol were obtained from Sigma-Aldrich. zVAD-fmk was from
Promega. ACR and NCS were gifts from R. Ishida (Aichi Cancer Center Re-
search Institute).
Yeast two-hybrid screening
cDNA encoding the full-length K8 or K18, provided by H. Eto (Massachu-
setts General Hospital, Boston, MA) was cloned into the yeast GAL4 DNA–
binding domain vector pYTH9  as described (Izawa et al., 2000). The result-
ing plasmids, pYTH9 -K8 and -K18 were used in the two-hybrid screen of a
human liver cDNA library fused to pACT2 vector (CLONTECH Laboratories,
Inc.), following the Matchmaker Two-Hybrid System Protocol (CLONTECH
Laboratories, Inc.). Positive clones were screened for their potential to grow
on selective medium containing 25 mM 3-aminotriazole and for the expres-
sion of  -galactosidase. Subsequent two-hybrid interaction analyses were
performed by cotransformation of plasmids, provided by P. James (The Uni-
versity of Wisconsin, Madison, WI), containing the GAL4 DNA–binding
(pGBD-C1) and –activation (pGAD-C1) domains into Saccharomyces cerevi-
siae strain Y190. K5 and K14 cDNAs, gifts from E. Fuchs (The University of
Chicago, Chicago, IL), were cloned into pGBD-C1 vectors. K8, K18, vimen-
tin, GFAP, and desmin cDNAs were also cloned into pGBD-C1 plasmids. A
series of truncations of K18 were constructed into the pGBD-C1 plasmid by
means of enzyme digestion and use of PCR techniques.
Cloning of full-length TRADD and DNA constructs
The full-length cDNA of human TRADD was amplified using a human liver
cDNA library (CLONTECH Laboratories, Inc.), PyroBest polymerase
(Takara), and a set of primers designed according to the human TRADD
cDNA sequence (Hsu et al., 1995). Various TRADD fragments, including
TRADD-N (aa 1–174), and TRADD-C (aa 245–312), were also produced by
PCR. Full-length TRADD and TRADD-C were cloned into yeast pGAD-C1
vectors. Sequences of these constructs were verified by DNA sequencing.
Purification of recombinant proteins
Recombinant TRADD-N protein was expressed as six consecutive His6-
tagged proteins, using pQE30 vectors (QIAGEN). Expression and purifica-
tion of the His6–TRADD-N protein were performed according to the manu-
facturer’s protocol (QIAGEN). Full-length TRADD and TRADD-N were
also expressed as GST fusion proteins in Escherichia coli and purified, es-
sentially as described (Smith and Johnson, 1988).
Filament assembly and cosedimentation assay
IF assembly in vitro was performed as described (Inagaki et al., 1987; Yano
et al., 1991). Briefly, purified K8 and K18 were dissolved at a 1:1 (mol/mol)
ratio in 10 mM Tris/HCl (pH 8.8), containing 50 mM 2-mercaptoethanol, 2
mM EGTA, 1 mM PMSF and 7 M urea. The mixture in 7 M urea solution was
dialyzed against a buffer of 10 mM Tris/HCl (pH 8.8), containing 50 mM
2-mercaptoethanol, 2 mM EGTA, and 1 mM PMSF, for 24 h at 4 C. These
heterotypic complexes of K8 and K18 (0.5 mg/ml) were incubated, with or
without GST or GST–TRADD in a buffer of 20 mM imidazole (pH 7.0), con-
taining 1 mM MgCl2 at 25 C for 1 h. Purified vimentin or desmin was assem-
bled in the presence or absence of GST–TRADD in a buffer of 25 mM Tris/
HCl (pH 7.5), containing 50 mM NaCl, at 25 C for 1 h. The reassembled
complexes were subjected to centrifugation at 15 krpm for 30 min. The su-
pernatants and precipitates were then analyzed using SDS-PAGE.
Generation of anti-TRADD antibody and immunoblotting
Anti-TRADD antibody was produced in rabbits injected with recombinant
His6–TRADD-N protein, and affinity purified with recombinant GST–
TRADD-N fusion protein. Lysates prepared from HMEC were separated by
SDS-PAGE, and transferred onto a polyvinylidene difluoride membrane
(Atto). The blots were incubated with anti-TRADD antibody and a horse-
radish peroxidase–conjugated second antibody, and immunoreactive
bands were visualized using chemiluminescence detection reagents (Re-
naissance; NEN Life Science Products).
Preparation of antiserum against cleavage site of caspase-8
Recently, we prepared antiserum against a cleavage site of mouse caspase-8
(TLEVD
387, anti-m8D387) (Kouroku et al., 2000a). Antiserum against a
cleavage site of human caspase-8 at D
401 was prepared basically as previ-
ously described (Kouroku et al., 1998). In brief, CYLEMD
401, a peptide cor-
responding to a COOH-terminal processing site (D
401) of human caspase-8
and cysteine, was synthesized (Sawady Technology Co., LTD.). Antiserum
against YLEMD (anti-h8D401) was generated by injecting CYLEMD conju-
gated to keyhole limpet hemocyanin (KLH) into rabbits. Anti-h8D401 anti-
body was purified by YLEMD-peptide affinity column chromatography.
Mammalian expression vectors and transfection
A cDNA–encoding full-length TRADD was cloned into the mammalian
expression vector pRK5-myc for expression of myc epitope–tagged pro-
teins. cDNAs encoding full-length mouse FADD, mouse caspase-2
(Nedd2), and human caspase-8 were provided by H. Ichijo (Tokyo Medi-
cal and Dental University, Tokyo, Japan), M. Noda (Kyoto University, Ky-
oto, Japan), and S. Yonehara (Kyoto University, Kyoto, Japan), respec-
tively, and were cloned into pCMV-Tag3 vectors (Stratagene) for
expression of myc epitope–tagged proteins. A cDNA encoding K8 dele-
tion mutant (aa 1–239) was also cloned into the pRK5-myc vector. Cells
were seeded onto 13-mm glass coverslips in six-well dishes the day be-
fore lipofection with 1  g of each plasmid, using LipofectAMINE PLUS or
2000 (GIBCO BRL) according to the manufacturer’s protocols. 16 h after
lipofection, the cells were fixed for immunofluorescence studies. SW13
cells were cotransfected with pCMVEBNA and pSV2neo plasmids
(CLONTECH Laboratories, Inc.) using LipofectAMINE PLUS as described
(Yasui et al., 1998). Cells expressing pCMVEBNA were cloned and main-
tained in the presence of G418 sulfate (GIBCO BRL). The EBNA-express-
ing SW13 cells were transiently transfected with myc-tagged K8 and K18,
myc-tagged NH2-terminus of K18 (aa 1–270), or vimentin cDNAs in
pDR2 plasmids, using LipofectAMINE PLUS, and then were treated with
various cytotoxic stimuli 24 h after the transfection.
Immunoprecipitation
Cells were lysed on ice for 20 min in lysis buffer consisting of 1% NP-40,
20 mM Tris/HCl (pH 7.5), 50 mM NaCl, 1 mM EDTA, 10  M PMSF, and
10  g/ml leupeptin. Lysates, clarified by centrifugation at 15 krpm for 30
min, were then incubated with anti-TRADD antibody or control rabbit
IgG, and immunocomplexes were immobilized on protein A agarose
beads (Sigma-Aldrich). Immunoprecipitates were analyzed by immuno-
blotting with anti-TRADD monoclonal antibody (Transduction Labora-
tory), anti-K18 monoclonal antibody (CY-90; Sigma-Aldrich), or anti-
TNFR1 monoclonal antibody (Santa Cruz Biotechnology, Inc.).
Immunofluorescence
Cells grown on 13-mm coverslips were fixed by incubation for 10 min in
50% methanol/50% acetone (vol/vol) at -20 C. For double staining for
TRADD and K18, cells were first incubated with anti-TRADD polyclonal anti-
body followed by Alexa 488-labeled anti–rabbit antibody (Molecular Probes).
Next, the cells were incubated with anti-K18 antibody (CY-90; Sigma-
Aldrich) followed by FluoroLink Cy3–linked anti–mouse antibody (Amer-
sham Pharmacia Biotech). To visualize myc tags, cells were reacted with anti-
myc monoclonal antibody (9E10) or anti-myc polyclonal antibody (Medical
and Biological Laboratories Co., Ltd.), followed by FluoroLink Cy3–linked
anti–mouse antibody or Alexa 488–labeled anti–rabbit antibody, respectively.
The coverslips were examined on an Olympus LSM-GB200 microscope.
UV irradiation and apoptosis assay
Cells were irradiated with UVC for 77 s (HMEC) or 23 s (EBNA-expressing
SW13 cells) after removal of medium and one wash with PBS, using a UVC
(254 nm) germicidal lamp, 1.3 J/m
2/s. The viability of cells obtained under
the different conditions was evaluated by Trypan blue staining. Nuclear
morphologic changes were evaluated by DAPI staining, and the number of
cells with no apoptotic nuclei (condensed chromatin and fragmented nu-
clei) was determined and the percentages of living cells were recorded.
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